Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with …
Background Angiotensin-converting enzyme-2 (ACE2) expression may increase due to
upregulation in patients using angiotensin-converting enzyme inhibitors (ACEI) and …
upregulation in patients using angiotensin-converting enzyme inhibitors (ACEI) and …
Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)
Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) …
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) …
Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients …
Importance It is unknown whether angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin II receptor blockers (ARBs) have a positive, neutral, or negative effect on clinical …
angiotensin II receptor blockers (ARBs) have a positive, neutral, or negative effect on clinical …
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open …
A Bauer, M Schreinlechner, N Sappler… - The Lancet …, 2021 - thelancet.com
Background SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme
2, which can be upregulated by inhibitors of the renin–angiotensin system (RAS). We aimed …
2, which can be upregulated by inhibitors of the renin–angiotensin system (RAS). We aimed …
ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust
DM Bean, Z Kraljevic, T Searle… - European Journal of …, 2020 - discovery.ucl.ac.uk
Aims: The SARS‐CoV‐2 virus binds to the angiotensin‐converting enzyme 2 (ACE2)
receptor for cell entry. It has been suggested that angiotensin‐converting enzyme inhibitors …
receptor for cell entry. It has been suggested that angiotensin‐converting enzyme inhibitors …
Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital …
DM Bean, Z Kraljevic, T Searle… - European journal of …, 2020 - Wiley Online Library
Abstract Aims The SARS‐CoV‐2 virus binds to the angiotensin‐converting enzyme 2
(ACE2) receptor for cell entry. It has been suggested that angiotensin‐converting enzyme …
(ACE2) receptor for cell entry. It has been suggested that angiotensin‐converting enzyme …
Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review
K Mackey, VJ King, S Gurley, M Kiefer… - Annals of internal …, 2020 - acpjournals.org
An update is available for this article. Background: The role of angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …
[PDF][PDF] Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
Objective: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Renin-angiotensin-aldosterone-system (RAAS) …
syndrome coronavirus 2 (SARS-CoV-2). Renin-angiotensin-aldosterone-system (RAAS) …
Outcomes in patients with COVID-19 infection taking ACEI/ARB
JS Rico-Mesa, A White, AS Anderson - Current cardiology reports, 2020 - Springer
Abstract Purpose of Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) is the virus responsible for the aggressive coronavirus disease (COVID-19) pandemic …
2) is the virus responsible for the aggressive coronavirus disease (COVID-19) pandemic …
Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Importance The chronic receipt of angiotensin-converting enzyme inhibitors (ACEIs) and
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …
相关搜索
- receptor blockers hospital trust
- angiotensin receptor enzyme inhibitors
- angiotensin receptor risks and impact
- receptor blockers ace inhibitors
- risks and impact enzyme inhibitors
- acei arb outcomes in patients
- receptor blockers sars covid19
- coronavirus disease enzyme inhibitors
- hospital trust enzyme inhibitors
- renin angiotensin clinical outcomes
- angiotensin receptor sars cov
- sars cov enzyme inhibitors
- enzyme inhibitor covid 19
- association of use enzyme inhibitors
- enzyme inhibitor organ support
- receptor blockers enzyme inhibitors